Xia Wang1, Tom J Moullaali2, Qiang Li1, Eivind Berge3, Thompson G Robinson4, Richard Lindley1,5, Danni Zheng1, Candice Delcourt1,6,7, Hisatomi Arima8, Lili Song9, Xiaoying Chen1, Jie Yang10, John Chalmers1, Craig S Anderson1,7,9, Else Charlotte Sandset11. 1. The George Institute for Global Health, University of New South Wales, Australia (X.W., Q.L., R.L., D.Z., C.D., X.C., J.C., C.S.A.). 2. Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (T.J.M.,). 3. Department of Cardiology, Oslo University Hospital, Norway (E.B.). 4. University of Leicester, Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, United Kingdom (T.G.R.). 5. Westmead Hospital, University of Sydney, NSW, Australia (R.L.). 6. Sydney Medical School, The University of Sydney, Australia (C.D.). 7. Neurology Department, Royal Prince Alfred Hospital, Sydney, NSW, Australia (C.D., C.S.A.). 8. Department of Public Health, Fukuoka University, Japan (H.A.). 9. The George Institute China at Peking University Health Science Centre, Beijing, PR China (L.S., C.S.A.). 10. Department of Neurology, the First Affiliated Hospital of Chengdu Medical College, China (J.Y.). 11. Department of Neurology, Oslo University Hospital, Norway (E.C.S.).
Abstract
BACKGROUND AND PURPOSE: Patient-centered care prioritizes patient beliefs and values towards wellbeing. We aimed to map functional status (modified Rankin Scale [mRS] scores) and health-related quality of life on the European Quality of Life 5-dimensional questionnaire (EQ-5D) to derive utility-weighted (UW) stroke outcome measures and test their statistical properties and construct validity. METHODS: UW-mRS scores were derived using linear regression, with mRS as a discrete ordinal explanatory response variable in 8 large international acute stroke trials. Linear regression models were used to validate UW-mRS scores by assessing differences in mean UW-mRS scores between the treatment groups of each trial. To explore the variability in EQ-5D between individual mRS categories, we generated receiver operator characteristic curves for EQ-5D to differentiate between sequential mRS categories and misclassification matrix to classify individual patients into a matched mRS category based on the closest UW-mRS value to their observed individual EQ-5D value. RESULTS: Among 22 946 acute stroke patients, derived UW-mRS across mRS scores 0 to 6 were 0.96, 0.83, 0.72, 0.54, 0.22, -0.18, and 0, respectively. Both UW-mRS and ordinal mRS scores captured divergent treatment effects across all 8 acute stroke trials. The sample sizes required to detect the treatment effects using UW-mRS scores as a continuous variable were almost half that required in trials for a binary cut point on the mRS. Area under receiver operator characteristic curves based on EQ-5D utility values varied from 0.66 to 0.81. Misclassification matrix showed moderate agreement between actual and matched mRS scores (kappa, 0.68 [95% CI, 0.67-0.68]). CONCLUSIONS: Medical strategies that target avoiding dependency may provide maximum benefit in terms of poststroke health-related quality of life. Despite variable differences with mRS scores, the UW-mRS provides efficiency gains as a smaller sample size is required to detect a treatment effect in acute stroke trials through use of continuous scores. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifiers: NCT00226096, NCT00716079, NCT01422616, NCT02162017, NCT00120003, NCT02123875. URL: http://ctri.nic.in; Unique identifier: CTRI/2013/04/003557. URL: https://www.isrctn.com; Unique identifier: ISRCTN89712435.
BACKGROUND AND PURPOSE:Patient-centered care prioritizes patient beliefs and values towards wellbeing. We aimed to map functional status (modified Rankin Scale [mRS] scores) and health-related quality of life on the European Quality of Life 5-dimensional questionnaire (EQ-5D) to derive utility-weighted (UW) stroke outcome measures and test their statistical properties and construct validity. METHODS: UW-mRS scores were derived using linear regression, with mRS as a discrete ordinal explanatory response variable in 8 large international acute stroke trials. Linear regression models were used to validate UW-mRS scores by assessing differences in mean UW-mRS scores between the treatment groups of each trial. To explore the variability in EQ-5D between individual mRS categories, we generated receiver operator characteristic curves for EQ-5D to differentiate between sequential mRS categories and misclassification matrix to classify individual patients into a matched mRS category based on the closest UW-mRS value to their observed individual EQ-5D value. RESULTS: Among 22 946 acute strokepatients, derived UW-mRS across mRS scores 0 to 6 were 0.96, 0.83, 0.72, 0.54, 0.22, -0.18, and 0, respectively. Both UW-mRS and ordinal mRS scores captured divergent treatment effects across all 8 acute stroke trials. The sample sizes required to detect the treatment effects using UW-mRS scores as a continuous variable were almost half that required in trials for a binary cut point on the mRS. Area under receiver operator characteristic curves based on EQ-5D utility values varied from 0.66 to 0.81. Misclassification matrix showed moderate agreement between actual and matched mRS scores (kappa, 0.68 [95% CI, 0.67-0.68]). CONCLUSIONS: Medical strategies that target avoiding dependency may provide maximum benefit in terms of poststroke health-related quality of life. Despite variable differences with mRS scores, the UW-mRS provides efficiency gains as a smaller sample size is required to detect a treatment effect in acute stroke trials through use of continuous scores. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifiers: NCT00226096, NCT00716079, NCT01422616, NCT02162017, NCT00120003, NCT02123875. URL: http://ctri.nic.in; Unique identifier: CTRI/2013/04/003557. URL: https://www.isrctn.com; Unique identifier: ISRCTN89712435.
Authors: Floris H B M Schreuder; Mirre Scholte; Marike J Ulehake; Lotte Sondag; Maroeska M Rovers; Ruben Dammers; Catharina J M Klijn; Janneke P C Grutters Journal: Front Neurol Date: 2022-06-02 Impact factor: 4.086
Authors: Daniela Pinter; Simon Fandler-Höfler; Viktoria Fruhwirth; Lisa Berger; Gerhard Bachmaier; Susanna Horner; Sebastian Eppinger; Markus Kneihsl; Christian Enzinger; Thomas Gattringer Journal: Front Neurol Date: 2022-04-25 Impact factor: 4.086
Authors: Anni Pohjola; Elias Oulasvirta; Risto P Roine; Harri P Sintonen; Ahmad Hafez; Päivi Koroknay-Pál; Hanna Lehto; Mika Niemelä; Aki Laakso Journal: Acta Neurochir (Wien) Date: 2021-04-16 Impact factor: 2.216